Development of MRI protocols for radiotherapy planning

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves non-patient volunteers who will undergo MRI scans using advanced MR-Linac and MRSIM technologies. The primary aim is to develop, optimize, and validate MRI protocols that can enhance radiotherapy planning and delivery. Participants will be required to provide written consent and undergo MRI safety screening, with their scans being read by a clinical radiologist for any incidental findings. The study is observational and does not involve any treatment interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Willing and able to provide written consent
* Volunteers must undergo and satisfy MRI safety screening
* Volunteers must be ≥ 16 years of age
* Participants must agree to registration as a non-patient in CWP (the Trust's Electronic Health Record - EHR- system) and have their MRIs read and reported for incidental findings by a clinical radiologist

Exclusion Criteria:

* Any contraindications to MRI identified after MRI safety screening including completion of an MRI Safety Screening Form
* Unable to tolerate MRI scan
* Known Pregnancy
* Known or suspected pathology in body region to be scanned
* Member of study team

Where it's running

• The Christie NHS FT
  Manchester, United Kingdom Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-stop MR-guided radiotherapy for urgent metastatic spinal cord compression

  This study will test whether an MR linear accelerator can deliver urgent single-appointment radiotherapy for people with metastatic spinal cord compression so they do not need a separate planning CT.

  Recruiting The Christie NHS Foundation Trust · Manchester · NCT06965101

• Proton Beam Therapy for Abdominal Neuroblastoma

  This study tests Proton Beam Therapy for children with abdominal neuroblastoma to see if it can reduce side effects while treating the cancer.

  Recruiting at 2 sites The Christie NHS Foundation Trust · London and 1 other locations · NCT06804447

• Exploring genomic testing for cancer of unknown primary

  This study is testing if genomic testing can help find the hidden source of cancer in patients with Cancer of Unknown Primary to improve treatment options and outcomes.

  Recruiting at 6 sites The Christie NHS Foundation Trust · Manchester, Greater Manchester and 5 other locations · NCT06695494

• Investigating bowel bacteria changes in prostate cancer patients undergoing radiotherapy

  This study is trying to see how the bacteria in the stool of prostate cancer patients change during and after pelvic radiotherapy and how these changes relate to their health and diet.

  Recruiting at 2 sites The Christie NHS Foundation Trust · Manchester, Greater Manchester and 1 other locations · NCT06640959

• Combined Proton Therapy and Liver Transplant for Hilar Cholangiocarcinoma

  This trial tests whether adding proton beam therapy plus chemotherapy and liver transplantation helps people with hilar cholangiocarcinoma.

  Recruiting at 2 sites The Christie NHS Foundation Trust · London and 1 other locations · NCT06434493

• Proton beam therapy for parotid cancer after surgery

  This study tests whether proton beam therapy after surgery can reduce side effects and improve outcomes for adults with malignant parotid gland cancer.

  Recruiting at 2 sites The Christie NHS Foundation Trust · London and 1 other locations · NCT06421649

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.